Living with brain cancer: From researcher to patient
As an academic researcher, my work-life revolves around testing the efficaciousness of pharmaceutical drugs on the prevention of cardiac dysfunction, arrhythmias, and sudden cardiac death in animal models of heart disease. I never thought I would go from someone<em> studying </em>a life-...
Main Authors: | Stephen Chelko, Daniel Fay |
---|---|
Format: | Article |
Language: | English |
Published: |
The Beryl Institute
2022-11-01
|
Series: | Patient Experience Journal |
Subjects: | |
Online Access: | https://pxjournal.org/journal/vol9/iss3/3 |
Similar Items
-
Vorasidenib in IDH1/2-mutant low-grade glioma: the grey zone of patient’s selection
by: Lidia Gatto, et al.
Published: (2024-01-01) -
Correlations of MGMT promoter methylation and IDH1 mutations with the clinical prognosis of malignant glioma patients
by: ZHANG Ning, MA Hui-hui, WANG Fan, LIANG Wei, WANG Yi-chun, WU Bing-shan, LI Qing-xin
Published: (2021-10-01) -
Preclinical Models of Low-Grade Gliomas
by: Pushan Dasgupta, et al.
Published: (2023-01-01) -
Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma
by: Marco Gallus, et al.
Published: (2023-07-01) -
Arterial Spin Labeling Perfusion in Determining the IDH1 Status and Ki-67 Index in Brain Gliomas
by: Artem I. Batalov, et al.
Published: (2022-06-01)